Regulatory Filings • Sep 14, 2023
Regulatory Filings
Open in ViewerOpens in native device viewer

Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its Spineway Academy department, with the support of GECO1 (Groupe d'études de la Chirurgie Osseuse – Bone Surgery Study Group) and its SAC (Spine Arthroplasty Community) working group, has organized a masterclass on cervical and lumbar disc prostheses with French and international surgeons. This event was held on September 9 in Behoust (France) and focused on total disc replacement using prostheses.
The event featured some 20 scientific papers and interactive round-table discussions led by opinion-leading surgeons who discussed their respective working practices and philosophies, and their experience with the prostheses used around the world and available in the various markets.
Over 60 French and international participants (USA, Mexico, Germany, UK, Spain, Luxembourg, Sweden, Switzerland, Thailand, India, Hong Kong, Australia) shared their experiences of disc replacement with cervical and lumbar disc prostheses.
On Monday September 11, Spineway Academy also held a training session on the implantation of its ESP prostheses at the l'Institut de Fer Moulin.
It gave surgeons from Germany, Thailand and Malaysia the chance to train, practice and work under the guidance of expert surgeons in disc arthroplasty, and in that way to consolidate their practice. Spineway would like to extend particular thanks to the German surgeons who attended the event, and notes that Germany is a strategic market for its premium products such as ESP prostheses.
The Spineway Academy department promotes scientific exchange and has the following main objectives:
1 A learned society whose purpose is to organize scientific conferences, publish scientific works, evaluate clinical results and provide medical training.
Since the beginning of the year, the Spineway Academy has trained more than 220 French and international surgeons. These events help promote the visibility of Spineway products and serve to strengthen the Group's reputation across its various geographies.
Next events:
September 19, 2023 – H1 2023 results October 4 to 6, 2023 – Eurospine meeting in Frankfurt October 12, 2023 – Q1 2023 revenue
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports. Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).
ISIN: FR001400BVK2 - ALSPW
Contacts:

Shareholder-services line Available Tuesday through Thursday +33 (0)806 706 060


Investor relations Solène Kennis [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.